20th February 2018
Draper Esprit has co-led in a $12.3 million fund raising by Evonetix, a Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis.
19th February 2018
Zilico, part of the Deepbridge Technology Growth EIS portfolio, has secured investment of £13.7 million in its latest funding round.
Deepbridge has contributed £3 million of this, with other backers including MaxHealth Medicine Group.
12th February 2018
LIfT BioSciences has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.
9th February 2018
A Nottingham regenerative medicine company which has developed a groundbreaking therapy that can help prevent sight loss has completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham.
The investment will allow NuVision Biotherapies to further develop its product range, strengthen its management team and increase sales in the UK and internationally.
7th February 2018
NanoFlex Limited, an early stage sensor design company, has secured £250,000 of funding from NPIF – Maven Equity Finance, part of the Northern Powerhouse Investment Fund (NPIF). The fund is delivered by MSIF working with Maven Capital Partners in the Liverpool City Region.
22nd January 2018
AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of neurodegenerative diseases including Alzheimer's disease, announced 14 million euros in series B funding led by Xerys.
18th January 2018
BGF has provided an investment of £10m to CHS Healthcare, a leading national provider of specialist services for the NHS. The funding will be used to expand CHS’s infrastructure and operations, supporting the provision of services to the NHS nationwide.
17th January 2018
BGF has made a significant minority investment in London Middlesex-based Revital, a multi-channel retailer of supplements, beauty and wellness products.
15th December 2017
Backed by £9 million of investment capital from NVM Private Equity and a private US investor, Medovate is the first company dedicated to the development and commercialisation of innovative medical technologies from within the NHS, which will commercially benefit the NHS.
11th December 2017
Discngine, a software company specializing in applications for life sciences research, today announces a Series A financing round of €1.1 million ($1.3M), received from Extens Développement e-Santé. The funds raised will allow Discngine to move forward with its Software-as-a-Service (SaaS) solution offering for the life sciences industry, a model that is not, as yet, widely used in this sector.
16th May 2017
The developers of a communication platform that offers secure digital access to healthcare services have received £200,000 of seed funding in a deal led by Mercia Fund Management and involving the NHS-backed West Midlands Academic Health Science Networks (AHSNs) fund.
15th May 2017
Footfalls & Heartbeats today announce a strategic investment round of £1.25m with The Enterprise Investment Scheme (EIS) tax relief. New product innovation is a key area of focus for Footfalls & Heartbeats, whose wearable technology is providing personalised, preventative healthcare, and solutions to aid the wellbeing of individuals.